Biomerica, Inc.BMRANASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +5.49% | +4.40% | +10.03% | -32.89% | -23.63% |
| Gross Profit Growth | -29.85% | +34.46% | +0.00% | -1320.00% | +46.71% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +0.00% | +1.78% | +1.78% | -42.28% | -84.31% |
| Weighted Average Shares Diluted Growth | +0.00% | +1.78% | +1.78% | -42.28% | -84.31% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +8.46% | +24.27% | +12.21% | -22.81% | -22.31% |
| Inventory Growth | +3.46% | -2.82% | -22.26% | -37.29% | -24.15% |
| Asset Growth | -40.46% | -38.52% | -28.68% | -35.76% | -12.91% |
| Book Value per Share Growth | -50.35% | -46.45% | -30.36% | +7.91% | +514.72% |
| Debt Growth | -30.07% | -33.19% | -37.01% | -41.66% | -47.24% |
| R&D Expense Growth | -37.08% | -37.62% | -36.73% | -4.91% | -28.62% |
| SG&A Expenses Growth | +16.04% | -22.88% | -32.89% | -16.76% | -2.21% |